News

Bayer makes glyphosate safety studies public

Bayer has made its more than 100 glyphosate safety studies public, as several trials against its acquired Monsanto RoundUp glyphosate weed killer are ongoing. Charlotte Morr is Bayer Crop Science data transparency manager, “So it’s no longer speculation about what could be in those studies. By enabling access, we really give the opportunity that people can look and judge for themselves. But, I mean, the message has been the same all over. Glyphosate is a safe product when it’s used according to the instructions.”

The Bayer studies are part of its summary submitted to the EU on RoundUp last December of more than 300 studies showing glyphosate is safe.

The CDC today released a toxicology report on glyphosate which Bayer officials say they are now reviewing.

Statement from Bayer’s Christi Dixon:

“We welcome another scientific perspective on what’s the most studied substance of its kind, glyphosate. Our experts have not had the opportunity to fully review the ATSDR profile in full detail, but we support constructive dialogue and the scientific rigor that’s inherent in the U.S. regulatory process. It’s important that we participate in the public comment period, and we’ll submit many of the same studies you see on our transparency platform. We continue to have full confidence in the safe use of glyphosate and believe that the extensive body of science, 40 years of real-world experience and the conclusions of regulators, including the U.S. EPA, European Food Safety Authority (EFSA), European Chemicals Agency (ECHA), German BfR, and Australian, Canadian, Korean, New Zealand and Japanese regulatory authorities, as well as the Joint FAO/WHO Meeting on Pesticide Residues (JMPR), confirm that glyphosate‐based products are safe when used as directed and that glyphosate is not carcinogenic.”

https://www.atsdr.cdc.gov/toxprofiles/tp214.pdf